Next Article 
Journal of Bacteriology, February 2001, p. 807-812, Vol. 183, No. 3
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.3.807-812.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
MexR Repressor of the mexAB-oprM
Multidrug Efflux Operon of Pseudomonas aeruginosa:
Identification of MexR Binding Sites in the mexA-mexR
Intergenic Region
Kelly
Evans,
Lateef
Adewoye, and
Keith
Poole*
Department of Microbiology and Immunology,
Queen's University, Kingston, Ontario, Canada, K7L 3N6
Received 30 May 2000/Accepted 1 November 2000
 |
ABSTRACT |
The MexR repressor of the mexAB-oprM multidrug efflux
operon of Pseudomonas aeruginosa was purified as a
C-terminal histidine-tagged protein by metal chelate affinity
chromatography. The purified protein was shown to bind ca. 200 bp
upstream of mexA, at two sites, each of which contains a
repeat of the nucleotide sequence GTTGA in inverse orientation. DNA
sequence analysis identified mexA and mexR
promoters within the MexR binding regions, consistent with the
previously observed negative regulation of mexR and
mexAB-oprM expression by MexR. Transcription of
mexA from the promoter originating within the MexR binding
site II was confirmed and shown to be markedly enhanced in a
nalB (i.e., mexR) mutant of P. aeruginosa. A second mexA promoter was also
identified, ca. 70 bp upstream of mexAB-oprM, and
transcription from this promoter appeared to occur in both the wild
type and a nalB mutant. Production of MexAB-OprM in
wild-type cells may be due to expression from a constitutively expressed proximal promoter, while MexAB-OprM hyperexpression in
nalB mutants is due to the additional expression from a
MexR-regulated distal promoter.
 |
INTRODUCTION |
In Pseudomonas
aeruginosa, the combination of multidrug efflux systems and low
outer membrane permeability produces an innate resistance to a wide
array of antimicrobial agents (10, 17, 25, 27). Several
multidrug efflux systems have been identified in P. aeruginosa, including MexAB-OprM (9, 31, 32),
MexCD-OprJ (30), MexEF-OprN (16), and
MexXY-OprM (1, 24). The Mex efflux systems are members of
a family of three component multidrug resistance efflux system
comprised of an inner membrane drug-proton antiporter of the
resistance-nodulation-division (RND) family (e.g., MexB), an outer
membrane efflux protein (e.g., OprM), and a membrane fusion protein
which couples the activities of the two membrane proteins (e.g., MexA)
(26).
Expression of MexCD-OprJ and MexEF-OprN appears to be lacking in
wild-type cells, at least under normal laboratory growth conditions,
occurring instead in nfxB (11, 22, 30) and
nfxC (8, 16, 22) multidrug-resistant mutants,
respectively. In contrast, both MexAB-OprM and MexXY-OprM are expressed
to some extent in wild-type cells, where they contribute to intrinsic resistance to aminoglycosides (MexXY-OprM) (1) and
-lactams, quinolones, chloramphenicol, tetracycline,
trimethoprim, sulfamethoxazole, and novobiocin (MexAB-OprM)
(15, 18, 33, 37, 38). Hyperexpression of MexAB-OprM and an
attendant increase in resistance to substrate antibiotics have also
been described for nalB (22, 38) and nalC (39) multidrug-resistant strains. Although
the nalB mutation is now known to occur in a gene,
mexR, encoding a repressor of mexAB-oprM
expression (33, 35, 39), the nature of the nalC mutation is not known. The mexR gene is located 274 bp
upstream of mexA and transcribed divergently from the efflux
genes (33). The association of mutations in
mexR with increased drug resistance of clinical strains
(13, 41) highlights the importance of studying the
regulation of the mexAB-oprM operon by MexR.
MexR belongs to the MarR family of regulatory proteins
(23), which includes PecS (34), CinR
(5), and Hpr (29). MarR, repressor of the
Escherichia coli multiple antibiotic resistance (marRAB) operon, binds the mar operator as a
dimer at two locations, recognizing a 5-bp sequence which occurs as an
inverted repeat (20). CinR, repressor of the
Butyrivibrio fibrisolvens E14 cinnamoyl ester
hydrolase-encoding gene (cinB), binds the
cinR-cinB intergenic region, which is known to contain two
16-bp inverted repeats, although binding to this sequence has yet to be
demonstrated (5). Hpr, a repressor of subtilisin
(aprE), neural protease (nprE), and the
oligopeptide permease (opp and app) operons of
Bacillus subtilis, binds at a 4-bp inverted repeat
(14). PecS regulates several genes associated with pectin
degradation in Erwinia chrysanthemi, although a consensus
binding sequence has not been identified (34). Members of
the MarR family are proposed to bind DNA through a conserved
helix-turn-helix motif or motifs (2, 5). In this study,
purified histidine-tagged MexR was used to confirm that MexR binds the
mexA-mexR intergenic region at two sites upstream of
mexR, near promoters for both mexR and
mexA.
 |
MATERIALS AND METHODS |
Bacterial strains and culture conditions.
E. coli
strain BL21/DE3(pLysE) (40) was host to the
mexR expression vector pKLE1, a pET23a derivative (see
below). P. aeruginosa wild-type strain K870
(33) and nalB strain OCR1 (21)
were also used. Bacteria were grown in Miller's Luria broth base
(Difco) containing 2 g of NaCl per liter of H2O (L
broth) supplemented with ampicillin (100 µg/ml) and/or
chloramphenicol (30 µg/ml) as indicated. Cultures were typically
grown at 37°C with vigorous shaking (200 rpm).
Plasmids.
To produce polyhistidine-tagged MexR (MexR-His),
the mexR gene was cloned into plasmid pET23a (Novagen,
Madison, Ws.). To achieve this, the mexR gene was amplified
from P. aeruginosa strain K870 chromosomal DNA using primers
K7 (5'-GGATTCATATGAACTACCCCGTGAATCCC-3'), which anneals at
the 5' end of mexR and incorporates an NdeI
restriction site, and K6 (5'-ATCGCTCGAGAATATCCTCAAGCGGTTGC-3'),
which anneals at the 3' end of mexR and incorporates
an XhoI restriction site. The reaction mixture (100 µl)
included 2 U of Vent DNA polymerase (New England Biolabs, Mississauga,
Ontario, Canada), 60 pmol of each primer, 0.2 mM each deoxynucleotide,
2.5 mM MgSO4, 10% (vol/vol) dimethyl sulfoxide, 1 µg of
chromosomal DNA, and 1× ThermoPol buffer. The mixture was treated for
5 min at 94°C, followed by 30 cycles of 2 min at 56°C, 1.5 min at
72°C, and 1 min at 94°C and finally 2 min at 56°C and 5 min at
72°C. Products were examined on a 0.8% (wt/vol) agarose gel and
purified with a QIAquick-spin PCR purification kit (Qiagen, Inc.,
Chatsworth, Calif.). The PCR product was digested with NdeI
and XhoI and cloned into
NdeI-XhoI-restricted pET23a, to produce pKLE1.
To isolate target DNA for the gel shift and DNase I footprinting
assays, the mexA-mexR intergenic region was cloned
into plasmid pCRII-TOPO (Invitrogen, Calif.). To achieve this, the
mexA-mexR intergenic region was amplified using primers K9
(5'-CTGAAGATCTGTTGCATAGCGTTGTCCTCA), which anneals to the 5'
end of mexA, and K10
(5'-ACGGGGTACCCGGGGTAGTTCATTGGTTTG-3'), which anneals to the
5' end of mexR. The reaction mixture (100 µl) included 2.5 U of Taq DNA polymerase (GibcoBRL, Burlington, Ontario,
Canada), 60 pmol of each primer, 0.2 mM each deoxynucleotide, 1.5 mM
MgCl2, 1 µg of P. aeruginosa strain K870
chromosomal DNA, and 1× Taq PCR buffer. PCR conditions were
as described above, except that the last elongation step at 72°C was
for 30 min instead of 5 min. After examination on a 0.8% (wt/vol)
agarose gel, the PCR product was cloned into pCRII-TOPO according to
the manufacturer's instructions for the TOPO TA Cloning kit
(Invitrogen). DNA sequencing confirmed the absence of PCR-induced
mutations in the resulting vector, pKLE2.
DNA techniques.
Plasmid transformations were carried out as
previously described (36), using competent cells prepared
by the method of Inoue et al. (12). Chromosomal DNA was
prepared as previously described (3). Midi-preparations of
plasmid DNA were prepared using Qiagen columns according to the method
supplied by the manufacturer, whereas mini-preparations of plasmid DNA
were prepared by the alkaline lysis procedure (36).
Restriction endonucleases and T4 DNA ligase were obtained from New
England Biolabs and used according to the manufacturer's instructions
or as described previously (36). Restriction fragments
were isolated, as required, from agarose gels (0.8% [wt/vol]) using
the Prep-a-Gene glass matrix (Bio-Rad, Mississauga, Ontario, Canada) as
recommended by the manufacturer. DNA sequencing was carried out by the
Laboratory Services Division, University of Guelph, Guelph, Ontario, Canada.
Purification of MexR.
An overnight culture of E. coli BL21/DE3(pLysE) carrying plasmid pKLE1 was diluted 1:100 into
250 ml of L broth supplemented with ampillicin (100 µg/ml) and
chloramphenicol (30 µg/ml) and incubated at 37°C until the culture
reached an optical density at 600 of 0.3 to 0.5. Expression of MexR-His
was then achieved by the addition of
isopropyl-
-D-thiogalactopyranoside (IPTG) at a final
concentration of 1 mM and incubation for a further 3 h. Bacteria
were harvested by centrifugation at 6,000 × g at 4°C
for 10 min, and the pellet was resuspended in 1 ml of lysis buffer (20 mM Tris-HCl [pH 8.0], 100mM NaCl) and stored at
20°C overnight.
The cells were subsequently lysed by sonication (two sonic bursts of
45 s, power 40 with a VibraCell sonicator [Sonics & Material
Inc., Danbury, Conn.T]). Unlysed cells and insoluble material were
removed by centrifugation at 16,000 × g at 4°C for 10 min, and the supernatant was recovered. The volume of the lysate was
brought up to 10 ml with lysis buffer, and 1 ml of Talon resin (Clontech, Palo Alto, Calif.), prepared according to the
manufacturer's instructions, was added. The lysate and resin were
gently agitated for 20 min at room temperature, at which time the resin
was pelleted by centrifugation at 3,000 × g at 4°C
for 5 min. Following removal of the supernatant, the resin was washed
three times by adding 10 ml of lysis buffer, agitating gently for 10 min, and repeating the centrifugation. A more stringent wash was then
carried out using lysis buffer containing 10 mM imidazole. The MexR-His
protein was eluted from the Talon resin by adding 0.5 ml of elution
buffer (lysis buffer containing 200 mM imidazole) and gently agitating for 10 min. Following centrifugation as for the wash steps, the MexR-His-containing supernatant was recovered. Protein concentration was determined by the Lowry assay (19), and purified
protein was stored at 4°C.
Gel shift assay.
The mexA-mexR intergenic region
cloned into pCRII-TOPO in producing pKLE2 is bracketed by
NotI and BglII cleavage sites present on
pCRII-TOPO. Owing to the existence of a NcoI cleavage site in the middle of the mexA-mexR intergenic region, then,
target DNA for gel shift experiments was recovered from pKLE2 by
digestion with NotI and NcoI (for the
mexR upstream region) or with BglII and
NcoI (for the mexA upstream region), yielding
fragments of 168 and 183 bp, respectively. The digested fragments were
end labeled with [
-32P]dGTP (3,000 Ci
mmol
1) using Klenow fragment (36) and
purified from an 8% (wt/vol) polyacrylamide gel by the crush-and-soak
method (36). The labeled DNA probes (3,000 cpm) were
incubated with purified MexR-His at concentrations ranging from 3.7 nM
to 15 µM for 15 min at room temperature in 20 µl of binding buffer
[20 mM HEPES (pH 7.6), 1 mM EDTA, 10 mM
(NH4)2SO4, 1 mM dithiothreitol
(DTT), 0.2% (wt/vol) Tween 20, 30 mM KC1] containing 1 µg of
poly(dI-dC) and 0.1 µg of poly-l-lysine. The reaction mixtures were
then submitted to electrophoresis on a nondenaturing 8% (wt/vol)
polyacrylamide gel in 0.25 × TBE (22 mM Tris, 22 mM boric acid,
0.5 mM EDTA [pH 8.0]), and the labeled DNA was visualized by
autoradiography. For competitor experiments, 0.5 µg of unlabeled DNA
was added to the reaction mixture prior to the addition of MexR-His.
DNase I footprinting assay.
DNase I footprinting was carried
out using a Sure Track footprinting kit (Amersham Pharmacia Biotech,
Baie d'Urfé, Quebec, Canada). Target DNA (mexR-mexA
intergenic region) was again recovered from pKLE2 by digestion with
EcoRV and BglII (for labeling of the
mexA coding strand) or with NotI and
SacI (for labeling the mexR coding strand),
yielding a fragment of 328 or 407 bp, respectively. The digested
fragments were end labeled with [
-32P]dGTP (3,000 Ci
mmol
1) using Klenow fragment (36) and
purified from an 8% (wt/vol) polyacrylamide gel by the crush-and-soak
method (36). Approximately 100,000 cpm of target DNA was
incubated for 15 min at room temperature with purified MexR-His (5 to
30 mM) in 50 µl of gel shift assay buffer containing 1 µg of
poly(dI-dC) and 0.1 µg of poly-L-lysine. The reaction
mixtures were adjusted to 1 mM MgCl2 and 0.5 mM
CaCl2 before the addition of 3 U of DNase I. Digestion was
performed at room temperature for 1 min and stopped by the addition of
140 µl of stop solution (192 mM sodium acetate, 32 mM EDTA, 0.14% [wt/vol] sodium dodecyl sulfate [SDS], 64 µg of yeast RNA
ml
1). After extraction with 200 µl of phenol-chloroform
(1:1, vol/vol), DNA fragments were ethanol precipitated and separated
by electrophoresis on an 8% (wt/vol) polyacrylamide-7 M urea
sequencing gel (36). The DNase I digestion profile was
subsequently revealed by autoradiography. A Maxam-Gilbert G+A
sequencing reaction was performed on 100,000 cpm of the appropriate
target DNA according to instructions provided with the SureTrack
footprinting kit.
Mapping the mexA transcription start site.
The
start of transcription of the mexA gene was determined by
the 5' rapid amplification of cDNA ends (RACE) protocol
(7) using a 5'/3' RACE kit essentially as recommended by
the manufacturer (Roche Diagnostics, Laval, Quebec, Canada). Total RNA
was prepared from P. aeruginosa strains K767 (wild type) and
K766 (nalB) using a Qiagen RNeasy Mini kit. DNA
contamination was removed by digestion with 10 U of RQ1 RNase-free
DNase (Promega) for 2 h at 37°C. Total RNA (2 µg) in a 20-µl
reaction volume was reverse transcribed at 55°C with avian
myeloblastosis virus reverse transcriptase and mexA-specific
primer JT-9 (5'-GGCGGGGTCGATCTGGTAGAGCTGCTG-3'), which
anneals 264 bp downstream of the mexA translational start site. A homopolymeric tail was appended to the 3' end of the
synthesized first-strand cDNA (corresponds to the 5' end of any
mexA mRNA that was reverse transcribed in the above
reaction) using terminal transferase and dATP by incubation at 37°C
for 20 min as described in the RACE kit protocol. The dA-tailed cDNA
was PCR amplified using an oligo (dT)-anchor primer
(5'-GACCACGCGTATC-GATGTCGACTTTTTTTTTTTTTTTTV-3' and another
mexA-specific primer (LA21 [5'
GAACAGGCGCTTGAGGAT-3']) which anneals 218 bp downstream of the
mexA translational start site. The PCR product obtained was
again PCR amplified with the nested mexA-specific primer
LA20 (5'AGGATGATGCCGTTCACCTG-3') and a kit-provided PCR
anchor primer (5' GACCACGCGTATCGATGTCGAC-3') in order to
eliminate any nonspecific PCR products from the first reaction. The
amplified products were purified using a High Pure PCR product
purification kit (Roche Diagnostics) and cloned into the pCR-Blunt II
TOPO vector (Invitrogen). Automated DNA sequencing of the RACE inserts
was performed by Cortec DNA Service Laboratories, Inc. (Queen's
University, Kingston, Ontario, Canada).
RT-PCR.
DNA-free total RNAs from P. aeruginosa
strains K767 (wild type) and K766 (nalB) prepared as
described above were reverse transcribed and subsequently PCR amplified
using primers K14 (5'-CGTCGCTGCCTTCCTTGAACA-3'; anneals 229 bp downstream of the mexA start codon) and LA19
(5'-GACCTTATCAACCTTGTTTCAGG-3'; anneals 185 bp upstream of
mexA coding region). The reaction was carried out using a
OneStep reverse transcription-PCR (RT-PCR) kit (Qiagen) according to
the manufacturer's instructions.
 |
RESULTS |
Purification of MexR.
The mexR gene was cloned into
the pET23a vector such that six histidine residues were added to the C
terminus of MexR. Overexpression of MexR-His was achieved by IPTG
induction of E. coli BL21/DE3 (pLysE) carrying plasmid pKLE1
(Fig. 1, lane 2). Metal affinity chromatography permitted ready purification of MexR-His at a
concentration of 5 mg/ml in the eluted fraction. When this fraction was
run on an SDS-polyacrylamide gel, we observed two major bands of
approximately 19 kDa, in good agreement with the predicted size of 17.9 kDa (molecular mass of MexR plus six histidines, although
higher-molecular-mass bands in multiples of 19 kDa were also present in
pKLE1 containing E. coli BL21/DE3(pLysE) (lane 4). These
bands were all absent in the control strain E. coli
BL21/DE3(pLysE) carrying the pET23a vector control (lane 5), indicating
that these high-molecular-mass proteins were derived from MexR-His.
Treatment of the MexR-His-containing fraction with DTT reduced the two
major bands to a single 19-kDa band and eliminated most of the
higher-molecular-mass species (lane 7). The latter, therefore, were
likely multimers of disulfide-bonded MexR-His, while the 19-kDa protein
that was eliminated by DTT treatment was probably a intramolecular
disulfide-bonded form of MexR (lane 7). These disulfide-bonded forms of
MexR-His were undoubtedly artifacts of the obvious hyperexpression of
the protein, such forms having been observed upon hyperexpression of
other regulatory proteins (6). The in vivo significance,
if any, of this disulfide bonding is unclear, although DTT-treated
MexR-His was active in gel shift and DNase I footprinting experiments
(see below).

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 1.
Overexpression and purification of MexR-His. E. coli BL21/DE3(pLysE) carrying pKLE1 (lanes 2 and 4) or pET23a
(lanes 3 and 5) was cultured as described in the text, and MexR-His was
purified from pKLE1-containing E. coli BL21/DE3(pLysE) by
metal chelate affinity chromatography (Talon). Lanes 1 and 6, molecular
mass markers; lanes 2 and 3, clarified lysate; lanes 4 and 5, eluant
from Talon column; lane 7, DTT (1.5% [wt/vol])-treated sample from
lane 4. The arrow indicates the location of the MexR-His monomer.
|
|
MexR binds to the mexA-mexR intergenic region.
DNA
from the mexA-mexR intergenic region was recovered from
pKLE2 by digestion with NotI and NcoI (for the
fragment upstream of the mexR translational start) or
BglII and NcoI (for the fragment upstream of the
mexA translation start) (see Fig. 4) and used to assess MexR
binding in a gel retardation assay (Fig.
2). MexR-dependent gel shifts were
observed for both fragments, although 1,000-fold more MexR-His was
needed to shift the mexA upstream region compared to the
mexR upstream region (lane 4 in Fig. 2A compared to lane 4 in Fig. 2B). Moreover, the interaction of MexR-His with the mexA upstream region was shown to be nonspecific, since
MexR-His binding to this fragment was lost in the presence of the
unrelated calf thymus DNA (Fig. 2A, lane 7). At least three MexR-DNA
complexes were observed for the mexR upstream region
fragment with increasing amounts of protein (Fig. 2B, lanes 2 to 6),
which is consistent with the presence of multiple binding sites (see
below). The smaller C1 and C2 complexes occurred at the lowest MexR-His
concentration (3.7 nM), while the largest, C3, occurred only at a very
high protein concentration (7.4 µM). Binding of MexR-His to the
mexR upstream region was shown to be specific, since
MexR-His binding to the labeled mexR upstream fragment was
abrogated in the presence of mexR upstream DNA (Fig. 2B,
lane 7) but not in the presence of unrelated calf thymus DNA (Fig. 2B,
lane 8). Consistent with the preferred binding of MexR-His to the
mexR upstream region, the unlabeled mexR upstream
fragment obviated the MexR shift of the mexA upstream
fragment (Fig. 2A, lane 6).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
Interaction of MexR with the mexA-mexR
intergenic region. (A) The 183-bp NcoI-BglII
fragment of pKLE2 containing the mexA upstream region was
incubated without MexR (lane 1) or with 3.7 µM (lane 2), 7.4 µM
(lane 3), or 15 µM (lane 4) MexR-His. This fragment was incubated
with 15 µM MexR and 0.5 µg of either unlabeled
NcoI-BglII fragment (lane 5),
NcoI-NotI fragment (lane 6), or calf thymus (lane
7) DNA as competitor DNA. (B) The 168-bp
NcoI-NotI fragment containing the mexR
upstream region was incubated without MexR (lane 1) or with 3.7 nM
(lane 2), 7.4 nM (lane 3), 15 nM (lane 4), 30 nM (lane 5), or 7.4 µM
(lane 6) MexR-His. This fragment was incubated with 30 nM MexR-His and
0.5 µg of either unlabeled NcoI-NotI fragment
(lane 7) or calf thymus (lane 8) DNA as competitor DNA. MexR-DNA
complexes (C1 to C3) and free DNA (F) are highlighted.
|
|
Identification of the MexR binding site.
The
mexA-mexR intergenic region was end labeled on either the
mexA or mexR coding strand and then subjected to
DNase I footprinting in an effort to ascertain the MexR binding
site(s). DNase I footprinting revealed two protected areas, dubbed
sites I and II, on both strands (Fig. 3A and
B). The protected areas, some 28 bp in
size, were separated by 3 bp and occurred 189 bp upstream of
mexA (from the 3' end of site I to the translational start
of mexA) and 25 bp upstream of mexR (from the 3'
end of site II to the translational start of mexR). No
binding of MexR-His was observed more proximal to mexA. The
locations of the MexR binding sites were therefore consistent with the
gel shift data. Within each binding site, the sequence 5'-GTTGA-3'
was repeated in inverse orientation after a space of 5 bp in the
same position within each site. Maxam-Gilbert sequencing of the
end-labeled DNA placed MexR binding site I overlapping the -35 region
of a second putative promoter for mexA (the originally predicted mexA promoter, here dubbed
P1mexA, was proximal to mexA
[33]) and the -10 region of the putative mexR
promoter (Fig. 3C). MexR binding site II overlaps the -35 region of the mexR promoter and the -10 region of the second putative
mexA promoter (Fig. 3C).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
DNase I footprinting of MexR-DNA interactions on the
mexA-mexR intergenic region. DNase I footprinting was
conducted with the 407-bp NotI-SacI fragment from
pKLE2 (which labels the mexR coding strand) (A) or the
328-bp NcoI-BglII fragment from pKLE2 (which
labels the mexA coding strand) (B) in the presence of no
MexR (lane 1) or 30 µM (lane 2), 60 µM (lane 3), 120 µM (lane 4),
or 180 µM (lane 5) MexR-His. The protected regions are bracketed at
the right and labeled I and II. The nucleotide sequence of the
protected region is indicated at the left, with bases identified in the
G+A sequencing reaction (lane G+A) shown in uppercase. (C) Nucleotide
sequence of the mexA-mexR intergenic region highlighting the
MexR binding sites (shaded) and 5'-GTTGA-3' inverted repeat
sequences (arrows) within each binding site. Putative mexA
and mexR -35/-10 promoter sequences are highlighted in bold
italics, and the +1 site (as determined by the RACE method [Fig. 5])
for the more distal of the two mexA promoters is underlined
and in boldface.
|
|
Identification of two transcriptional start sites for
mexA.
The lack of specific MexR binding proximal to
mexA led to the recognition of a putative, more distal,
second promoter (P2mexA [Fig. 3C and
4]), which is bound by MexR. Consensus
35/
10 hexamers were identified within the region protected by MexR,
suggesting a mechanism by which MexR could negatively regulate
mexA or mexAB-oprM expression. To confirm the
activity of this distal mexAB-oprM promoter, RT-PCR was
performed on total cellular RNA using primers that anneal at MexR
binding site II (LA19) and within the mexA coding region
(K14) (Fig. 4). Large amounts of the expected ca. 400-bp RT-PCR product
(Fig. 4) were obtained from nalB strain OCR1 (Fig. 5A, lane
2), though barely detectable levels of
this product were observed for wild-type strain PAO1 (K767) (Fig. 5A, lane 3). This was consistent both with the presence of mexA
(i.e., mexAB-oprM) transcripts that extend at least as far
as MexR binding site II and with the increased production of these
transcripts in a nalB (i.e., mexR) mutant.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic showing the positions of promoters and MexR
binding sites within the mexA-mexR intergenic region. The
relative positions and orientations of PmexR,
P1mexA, P2mexA, and MexR
binding sites I and II (from Fig. 3) are highlighted. Restriction sites
marked with an asterisk do not occur within the mexA-mexR
coding coding or intergenic sequence but instead flank the cloned
intergenic region in plasmid pKLE2. They are indicated here to
illustrate the specific portion of the mexA-mexR intergenic
region that was encompassed by the restriction fragments used in the
gel shift experiments in Fig. 2. The relative locations of RT-PCR and
RACE primers (Fig. 5) as well as the predicted amplification products
are also highlighted. Placement of the RACE anchor primers corresponds
with the predicted transcription starts sites for mexA.
|
|

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
Identification and mapping of mexA
transcripts. (A) RT-PCR of total RNA from P. aeruginosa
strains OCR1 (nalB) (lane 2) and PAO1 (K767) (lane 3) using
primers K14 and LA19 (Fig. 4). The 564-bp HindIII
fragment is shown in lane 1. (B) 5' RACE products from P. aeruginosa strains OCR1 (nalB) (lane 2) and PAO1 (K767)
(lane 3) prepared with the mexA-specific LA20 primer and the
PCR anchor primer provided with the RACE kit (Roche). A 293-bp RACE
product produced using control template and primers provided with the
RACE kit is shown in lane 1. The migration position of the 564-bp HindIII fragment is shown at the right.
|
|
To more precisely map the transcription start site for the putative
P2
mexA, the RACE procedure was used. The basis
of this method is the cloning and nucleotide sequencing of cDNAs
derived from the reverse transcription and subsequent amplification
of,
in this case, the 5' end of each
mexAB-oprM mRNA (see
Materials
and Methods). Using this procedure, an expected 450-bp
mexA-derived
cDNA (Fig.
4, anchor-2 and LA20 primers) was
recovered from the
nalB mutant OCR1 (Fig.
5B, lane 2, top
band), and its sequencing
confirmed that expression from
P2
mexA initiates at a
cytosine residue
appropriately placed downstream of the predicted
-10 site for this
promoter (Fig.
3C). No 430-bp cDNA was recovered
from wild-type strain
PAO1 (K767) (Fig.
5B, lane 3), consistent
with the minimal expression
expected from P2
mexA in this
MexR
+
strain and in agreement with the RT-PCR results described above.
Interestingly, a second
mexA-derived cDNA was recovered from
both
the wild type and
nalB mutant (Fig.
5B, lanes 2 and 3).
The size
of this DNA, ca. 300 bp, is consistent with the existence in
these
strains of a
mexA transcript that initiates within the
vicinity
of the proximal P1
mexA promoter (Fig.
4, anchor-1 and
LA20 primers). Cloning and sequencing of these cDNAs
failed, however,
to consistently identify a single reside as the
initiation
site.
 |
DISCUSSION |
The binding site for MexR appears to involve an inverted repeat of
the sequence GTTGA that by analogy with MarR likely constitutes the
binding site for a MexR monomer (20) (i.e., the binding site itself accommodates a dimer). MarR (20) and other
members of this family, including EmrR (4) and SlyA
(28), are known to form oligomers; CinR, which also
apparently recognizes an inverted repeat sequence, is also predicted to
operate as a dimer (5). As for MarR (20), two
closely linked binding sites were identified for MexR and dubbed sites
I and II. MarR binding sites spanned both the
35/
10 hexamers of the
marRAB promoter and the MarR ribosome binding site, but
binding at the MarR ribosome binding site is not necessary either for
MarR binding to the
35/
10 hexamers or for repression of the
mar operon (20). Here, both MexR binding sites
overlap components of the mexR and mexA
promoters, and thus occupancy of either site would interfere with
mexR and mexAB-oprM expression.
The lack of MexR binding more proximal to mexA, in the
vicinity of a previously proposed promoter sequence (shown here to indeed function as a promoter), was initially surprising, given the
known MexR repression of mexAB-oprM expression
(33). The presence of a second mexA promoter,
which occurs substantially upstream of mexA and in the
vicinity of a MexR binding site, provided a ready explanation. The
observation that a mexA transcript is produced from
P2mexA and that the levels of this transcript increase markedly in a MexR-deficient (nalB) strain clearly
demonstrate that P2mexA is functional and that
MexR regulates expression of mexAB-oprM via this promoter.
Data provided here also suggests that P1mexA,
the proximal promoter first identified as a mexAB-oprM
promoter, is a functional promoter, possibly responsible for the modest
mexAB-oprM expression and corresponding multidrug resistance
of wild-type P. aeruginosa. Still, it is also possible that
the RACE product that implicates P1mexA as an
active promoter is a stable breakdown product of the
P2mexA-derived RACE product or that the mRNA
originating from P2mexA is itself unstable,
yielding 5'-truncated RACE products during the reverse transcription
and amplification steps of the RACE reaction. In this case,
mexAB-oprM expression would initiate from a single
MexR-regulated promoter located substantially upstream of
mexA (i.e., P2mexA). In any case,
hyperexpression of MexAB-OprM in nalB multidrug-resistant
strains is due to enhanced mexAB-oprM transcription arising
from P2mexA. The functional significance of the
lengthy untranslated leader that results from expression from this
promoter is unclear, although it may play a role in
mexAB-oprM expression mediated by mutations in
nalC (39).
 |
ACKNOWLEDGMENTS |
This work was supported by an operating grant from the Canadian
Cystic Fibrosis Foundation (CCFF). K.E. holds a CCFF studentship. L.A.
is supported by the Canadian Bacterial Diseases Network (a consortium
of the Centres of Excellence Program). K.P. is a CCFF Scholar.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Queen's University, Kingston, Ontario,
Canada K7L 3N6. Phone: (613) 533-6677. Fax: (613) 533-6796. E-mail:
poolek{at}post.queensu.ca.
 |
REFERENCES |
| 1.
|
Aires, J. R.,
T. Köhler,
H. Nikaido, and P. Plesiat.
1999.
Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
Antimicrob. Agents Chemother.
43:2624-2628[Abstract/Free Full Text].
|
| 2.
|
Alekshun, M. N.,
Y. S. Kim, and S. B. Levy.
2000.
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding.
Mol. Microbiol.
35:1394-1404[CrossRef][Medline].
|
| 3.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1992.
Short protocols in molecular biology, 2nd ed.
John Wiley & Sons, Inc., New York, N.Y.
|
| 4.
|
Brooun, A.,
J. J. Tomashek, and K. Lewis.
1999.
Purification and ligand binding of EmrR, a regulator of a multidrug transporter.
J. Bacteriol.
181:5131-5133[Abstract/Free Full Text].
|
| 5.
|
Dalrymple, B. P., and Y. Swadling.
1997.
Expression of a Butyrivibrio fibrisolvens E14 gene (cinB) encoding an enzyme with cinnamoyl ester hydrolase activity is negatively regulated by the product of an adjacent gene (cinR).
Microbiology
143:1203-1210[Abstract/Free Full Text].
|
| 6.
|
Dean, C. R.,
S. Neshat, and K. Poole.
1996.
PfeR, an enterobactin-responsive activator of ferric enterobactin receptor gene expression in Pseudomonas aeruginosa.
J. Bacteriol.
178:5361-5369[Abstract/Free Full Text].
|
| 7.
|
Frohman, M. A.
1993.
Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE.
Methods Enzymol.
218:340-356[Medline].
|
| 8.
|
Fukuda, H.,
M. Hosaka,
K. Hirai, and S. Iyobe.
1990.
New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
Antimicrob. Agents Chemother.
34:1757-1761[Abstract/Free Full Text].
|
| 9.
|
Gotoh, N.,
H. Tsujimoto,
K. Poole,
J.-I. Yamagishi, and T. Nishino.
1995.
The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon.
Antimicrob. Agents Chemother.
39:2567-2569[Abstract].
|
| 10.
|
Hancock, R. E. W.
1997.
The bacterial outer membrane as a drug barrier.
Trends Microbiol.
5:37-42[CrossRef][Medline].
|
| 11.
|
Hirai, K.,
S. Suzue,
T. Irikura,
S. Iyobe, and S. Mitsuhashi.
1987.
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
31:582-586[Abstract/Free Full Text].
|
| 12.
|
Inoue, H.,
H. Nojima, and H. Okayama.
1991.
High efficiency transformation of Escherichia coli with plasmids.
Gene
96:23-28.
|
| 13.
|
Jalal, S., and B. Wretlind.
1998.
Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Microbiol. Drug Resist.
4:257-261.
|
| 14.
|
Kallio, P. T.,
J. E. Fagelson,
J. A. Hoch, and M. A. Strauch.
1999.
The transition state regulator Hpr of Bacillus subtilis is a DNA-binding protein.
J. Biol. Chem.
266:13417.
|
| 15.
|
Koehler, T.,
M. Kok,
M. Michea-Hamzehpour,
P. Plesiat,
N. Gotoh,
T. Nishino,
L. Kocjanici Curty, and J.-C. Pechere.
1996.
Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
40:2288-2290[Abstract].
|
| 16.
|
Koehler, T.,
M. Michea-Hamzehpour,
U. Henze,
N. Gotoh,
L. K. Curty, and J.-C. Pechere.
1997.
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa.
Mol. Microbiol.
23:345-354[CrossRef][Medline].
|
| 17.
|
Li, X.-Z.,
L. Zhang, and K. Poole.
2000.
Interplay between the MexAB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa.
J. Antimicrob. Chemother.
45:433-436[Abstract/Free Full Text].
|
| 18.
|
Li, X.-Z.,
L. Zhang,
R. Srikumar, and K. Poole.
1998.
-Lactamase inhibitors are substrates of the multidrug efflux pumps of Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
42:399-403[Abstract/Free Full Text].
|
| 19.
|
Lowry, O. H.,
A. L. Rosenbrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 20.
|
Martin, R. G., and J. L. Rosner.
1995.
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.
Proc. Natl. Acad. Sci. USA
92:5456-5460[Abstract/Free Full Text].
|
| 21.
|
Masuda, N., and S. Ohya.
1992.
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
36:1847-1851[Abstract/Free Full Text].
|
| 22.
|
Masuda, N.,
E. Sakagawa, and S. Ohya.
1995.
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
39:645-649[Abstract].
|
| 23.
|
Miller, P. F., and M. C. Sulavik.
1996.
Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.
Mol. Microbiol.
21:441-448[CrossRef][Medline].
|
| 24.
|
Mine, T.,
Y. Morita,
A. Kataoka,
T. Mitzushima, and T. Tsuchiya.
1999.
Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
43:415-417[Abstract/Free Full Text].
|
| 25.
|
Nikaido, H.
1994.
Prevention of drug access to bacterial targets: permeability barriers and active efflux.
Science
264:382-388[Abstract/Free Full Text].
|
| 26.
|
Nikaido, H.
1998.
Multiple antibiotic resistance and efflux.
Curr. Opin. Microbiol.
1:516-523[CrossRef][Medline].
|
| 27.
|
Nikaido, H.
1998.
The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?
Drug Res. Updates
1:93-98.
|
| 28.
|
Oscarsson, J.,
Y. Mizunoe,
B. E. Uhlin, and D. J. Haydon.
1996.
Induction of haemolytic activity in Escherichia coli by the slyA gene product.
Mol. Microbiol.
20:191-199[Medline].
|
| 29.
|
Perego, M., and J. A. Hoch.
1988.
Sequence analysis and regulation of the hpr locus, a regulatory gene for protease production and sporulation in Bacillus subtilis.
J. Bacteriol.
170:2560-2567[Abstract/Free Full Text].
|
| 30.
|
Poole, K.,
N. Gotoh,
H. Tsujimoto,
Q. Zhao,
A. Wada,
T. Yamasaki,
S. Neshat,
J.-I. Yamagishi,
X.-Z. Li, and T. Nishino.
1996.
Overexpression of the mexC-mexD-oprJ efflux operon in nfxB multidrug resistant strains of Pseudomonas aeruginosa.
Mol. Microbiol.
21:713-724[CrossRef][Medline].
|
| 31.
|
Poole, K.,
D. E. Heinrichs, and S. Neshat.
1993.
Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine.
Mol. Microbiol.
10:529-544[CrossRef][Medline].
|
| 32.
|
Poole, K.,
K. Krebes,
C. McNally, and S. Neshat.
1993.
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.
J. Bacteriol.
175:7363-7372[Abstract/Free Full Text].
|
| 33.
|
Poole, K.,
K. Tetro,
Q. Zhao,
S. Neshat,
D. Heinrichs, and N. Bianco.
1996.
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression.
Antimicrob. Agents Chemother.
40:2021-2028[Abstract].
|
| 34.
|
Reverchon, S.,
W. Nasser, and J. Robert-Baudouy.
1994.
pecS; a locus controlling pectinase, cellulase and blue pigment production in Erwinia chrysanthemi.
Mol. Microbiol.
11:1127-1139[CrossRef][Medline].
|
| 35.
|
Saito, K.,
H. Yoneyama, and T. Nakae.
1999.
nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome.
FEMS Microbiol. Lett.
179:67-72[CrossRef][Medline].
|
| 36.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 37.
|
Srikumar, R.,
T. Kon,
N. Gotoh, and K. Poole.
1998.
Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
Antimicrob. Agents Chemother.
42:65-71[Abstract/Free Full Text].
|
| 38.
|
Srikumar, R.,
X.-Z. Li, and K. Poole.
1997.
Inner membrane efflux components are responsible for the -lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
J. Bacteriol.
179:7875-7881[Abstract/Free Full Text].
|
| 39.
|
Srikumar, R.,
C. J. Paul, and K. Poole.
2000.
Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
J. Bacteriol.
182:1410-1414[Abstract/Free Full Text].
|
| 40.
|
Studier, F. W.,
A. H. Rosenberg,
J. J. Dunn, and J. W. Dubendorff.
1990.
Use of T7 RNA polymerase to direct expression of cloned genes.
Methods Enzymol.
185:60-89[Medline].
|
| 41.
|
Ziha-Zarifi, I.,
C. Llanes,
T. Koehler,
J.-C. Pechere, and P. Plesiat.
1999.
In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.
Antimicrob. Agents Chemother.
43:287-291[Abstract/Free Full Text].
|
Journal of Bacteriology, February 2001, p. 807-812, Vol. 183, No. 3
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.3.807-812.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kumarevel, T., Tanaka, T., Umehara, T., Yokoyama, S.
(2009). ST1710-DNA complex crystal structure reveals the DNA binding mechanism of the MarR family of regulators. Nucleic Acids Res
0: gkp496v1-gkp496
[Abstract]
[Full Text]
-
Vettoretti, L., Plesiat, P., Muller, C., El Garch, F., Phan, G., Attree, I., Ducruix, A., Llanes, C.
(2009). Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Antimicrob. Agents Chemother.
53: 1987-1997
[Abstract]
[Full Text]
-
Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K., Ike, Y.
(2008). Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas aeruginosa, but Use of the High-Potency Drug Doripenem Inhibits Mutant Formation. Antimicrob. Agents Chemother.
52: 3795-3800
[Abstract]
[Full Text]
-
Wilke, M. S., Heller, M., Creagh, A. L., Haynes, C. A., McIntosh, L. P., Poole, K., Strynadka, N. C. J.
(2008). The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR. Proc. Natl. Acad. Sci. USA
105: 14832-14837
[Abstract]
[Full Text]
-
Chen, H., Hu, J., Chen, P. R., Lan, L., Li, Z., Hicks, L. M., Dinner, A. R., He, C.
(2008). The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc. Natl. Acad. Sci. USA
105: 13586-13591
[Abstract]
[Full Text]
-
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C., Dean, C. R., Poole, K.
(2007). Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J. Bacteriol.
189: 5441-5451
[Abstract]
[Full Text]
-
Okada, N., Oi, Y., Takeda-Shitaka, M., Kanou, K., Umeyama, H., Haneda, T., Miki, T., Hosoya, S., Danbara, H.
(2007). Identification of amino acid residues of Salmonella SlyA that are critical for transcriptional regulation. Microbiology
153: 548-560
[Abstract]
[Full Text]
-
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P.
(2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev.
20: 79-114
[Abstract]
[Full Text]
-
Morita, Y., Cao, L., Gould, V. C., Avison, M. B., Poole, K.
(2006). nalD Encodes a Second Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa. J. Bacteriol.
188: 8649-8654
[Abstract]
[Full Text]
-
Buroni, S., Manina, G., Guglierame, P., Pasca, M. R., Riccardi, G., De Rossi, E.
(2006). LfrR Is a Repressor That Regulates Expression of the Efflux Pump LfrA in Mycobacterium smegmatis. Antimicrob. Agents Chemother.
50: 4044-4052
[Abstract]
[Full Text]
-
Quale, J., Bratu, S., Gupta, J., Landman, D.
(2006). Interplay of Efflux System, ampC, and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates.. Antimicrob. Agents Chemother.
50: 1633-1641
[Abstract]
[Full Text]
-
Chan, Y. Y., Chua, K. L.
(2005). The Burkholderia pseudomallei BpeAB-OprB Efflux Pump: Expression and Impact on Quorum Sensing and Virulence. J. Bacteriol.
187: 4707-4719
[Abstract]
[Full Text]
-
Sobel, M. L., Hocquet, D., Cao, L., Plesiat, P., Poole, K.
(2005). Mutations in PA3574 (nalD) Lead to Increased MexAB-OprM Expression and Multidrug Resistance in Laboratory and Clinical Isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 1782-1786
[Abstract]
[Full Text]
-
Chuanchuen, R., Gaynor, J. B., Karkhoff-Schweizer, R., Schweizer, H. P.
(2005). Molecular Characterization of MexL, the Transcriptional Repressor of the mexJK Multidrug Efflux Operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 1844-1851
[Abstract]
[Full Text]
-
Lin, J., Akiba, M., Sahin, O., Zhang, Q.
(2005). CmeR Functions as a Transcriptional Repressor for the Multidrug Efflux Pump CmeABC in Campylobacter jejuni. Antimicrob. Agents Chemother.
49: 1067-1075
[Abstract]
[Full Text]
-
Wilkinson, S. P., Grove, A.
(2004). HucR, a Novel Uric Acid-responsive Member of the MarR Family of Transcriptional Regulators from Deinococcus radiodurans. J. Biol. Chem.
279: 51442-51450
[Abstract]
[Full Text]
-
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., Plesiat, P.
(2004). Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously. Antimicrob. Agents Chemother.
48: 1797-1802
[Abstract]
[Full Text]
-
Maseda, H., Sawada, I., Saito, K., Uchiyama, H., Nakae, T., Nomura, N.
(2004). Enhancement of the mexAB-oprM Efflux Pump Expression by a Quorum-Sensing Autoinducer and Its Cancellation by a Regulator, MexT, of the mexEF-oprN Efflux Pump Operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
48: 1320-1328
[Abstract]
[Full Text]
-
Lee, E.-H., Rouquette-Loughlin, C., Folster, J. P., Shafer, W. M.
(2003). FarR Regulates the farAB-Encoded Efflux Pump of Neisseria gonorrhoeae via an MtrR Regulatory Mechanism. J. Bacteriol.
185: 7145-7152
[Abstract]
[Full Text]
-
Saito, K., Akama, H., Yoshihara, E., Nakae, T.
(2003). Mutations Affecting DNA-Binding Activity of the MexR Repressor of mexR-mexA-mexB-oprM Operon Expression. J. Bacteriol.
185: 6195-6198
[Abstract]
[Full Text]
-
Parke, D., Ornston, L. N.
(2003). Hydroxycinnamate (hca) Catabolic Genes from Acinetobacter sp. Strain ADP1 Are Repressed by HcaR and Are Induced by Hydroxycinnamoyl-Coenzyme A Thioesters. Appl. Environ. Microbiol.
69: 5398-5409
[Abstract]
[Full Text]
-
Hocquet, D., Bertrand, X., Kohler, T., Talon, D., Plesiat, P.
(2003). Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone. Antimicrob. Agents Chemother.
47: 1887-1894
[Abstract]
[Full Text]
-
Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., Plesiat, P.
(2003). MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother.
47: 1371-1375
[Abstract]
[Full Text]
-
Grkovic, S., Brown, M. H., Skurray, R. A.
(2002). Regulation of Bacterial Drug Export Systems. Microbiol. Mol. Biol. Rev.
66: 671-701
[Abstract]
[Full Text]
-
Lim, D., Poole, K., Strynadka, N. C. J.
(2002). Crystal Structure of the MexR Repressor of the mexRAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa. J. Biol. Chem.
277: 29253-29259
[Abstract]
[Full Text]
-
Adewoye, L., Sutherland, A., Srikumar, R., Poole, K.
(2002). The MexR Repressor of the mexAB-oprM Multidrug Efflux Operon in Pseudomonas aeruginosa: Characterization of Mutations Compromising Activity. J. Bacteriol.
184: 4308-4312
[Abstract]
[Full Text]
-
Providenti, M. A., Wyndham, R. C.
(2001). Identification and Functional Characterization of CbaR, a MarR-Like Modulator of the cbaABC-Encoded Chlorobenzoate Catabolism Pathway. Appl. Environ. Microbiol.
67: 3530-3541
[Abstract]
[Full Text]